-Reuters
Barclays Maintains Overweight on Tenet Healthcare, Announces $67 Price Target
Barclays analyst Sarah James maintains Tenet Healthcare (NYSE:THC) with a Overweight and announces $67 price target.
Related Posts
Why 7 Apple Analysts Say Investors Should Take A Bite Of The Stock After Q1 Blowout
Apple Inc (NASDAQ: AAPL) reported Thursday strong quarterly results, buoyed by across-the-board strength.
Here’s How Much $1000 Invested In Equinix 10 Years Ago Would Be Worth Today
Equinix (NASDAQ:EQIX) has outperformed the market over the past 10 years by 3.3% on an annualized basis producing an average annual return of 14.95%. Currently, Equinix has a market capitalization of $64.69 billion.
Morgan Stanley Maintains Equal-Weight on Principal Finl Gr, Raises Price Target to $68
Morgan Stanley analyst Nigel Dally maintains Principal Finl Gr (NASDAQ:PFG) with a Equal-Weight and raises the price target from $65 to $68.